|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.64 AUD | -2.40% |
|
0.00% | +30.71% |
| 04-17 | Telix Pharmaceuticals Says JPMorgan Increases Stake | MT |
| 04-16 | Telix Enters Attractive Market With Late-Stage Brain Cancer Drug Trial in US, Jefferies Says | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 15.77 | 16.95 | 15.22 |
| Spread/Res. | -7.17% | -13.63% | -3.81% |
| Spread/Supp. | +13.05% | +69.64% | +67.12% |
| Support | 12.95 | 8.63 | 8.76 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- TLX Stock
- Charts Telix Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition